ImmunityBio Inc - Common Stock — Quarterly Financial Statistics (NASDAQ:IBRX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -85.14 M-85.91 M-79.75 M-68.91 M-70.38 M -304.94 M Cash from investing activities 9.83 M4.13 M-16.14 M-181.36 M43.57 M -149.8 M Cash from financing activities 106.93 M-982 K172.81 M173.52 M54.89 M 400.24 M Free cash flow -87.25 M-87.03 M-80.83 M-69.65 M-71.28 M -308.78 M

뉴스

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)

ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?

ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims

“FDA Warning” on Cancer Drug Sends ImmunityBio Stock (IBRX) Tumbling over 26% - TipRanks.com

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

ImmunityBio Crashes On FDA Warning Over Anktiva Claims - ImmunityBio (NASDAQ:IBRX)

Can Anktiva's Label Expansion Unlock the Next Growth Phase for IBRX?

ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion